Synvista Therapeutics, Inc. (SYNI)
OTCMKTS · Delayed Price · Currency is USD
0.000001
0.00 (0.00%)
At close: Dec 30, 2025
Synvista Therapeutics Market Cap
Synvista Therapeutics has a market cap or net worth of $3 as of July 21, 2026. Its market cap has decreased by -98.84% in one year.
Market Cap
3.00
Enterprise Value
n/a
Revenue
54.73K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since November 1, 1991, Synvista Therapeutics's market cap has decreased from 330.80M to 3.00, a decrease of -100.00%. That is a compound annual growth rate of -41.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 3.00 | - |
| Dec 30, 2020 | 3.00 | -88.46% |
| Dec 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 808.75M |
| Veradigm | 517.71M |
| Silence Therapeutics | 495.96M |
| Elite Pharmaceuticals | 418.18M |
| Adynxx | 6.00 |
| OncoSec Medical | 6.00 |
| GlobeImmune | 6.00 |
| Neptune Wellness Solutions | 5.00 |